2026
25 March, 2026
Minutes from Annual General Meeting in FluoGuide A/S
Copenhagen, Denmark, 25 March 2026 – FluoGuide A/S (“FluoGuide” or the “Company”) held its annual general...
Copenhagen, Denmark, 18 March 2026 – FluoGuide A/S (“FluoGuide” or the “Company”), a biotech company...
10 March, 2026
Notice of Annual General Meeting in FluoGuide A/S
The board of directors hereby convenes the Annual General Meeting of FluoGuide A/S, company registration (CVR) no. 39 29 64 38 (the...
25 February, 2026
FluoGuide A/S publishes annual report for the fiscal year 2025
Copenhagen, Denmark, 25 February 2026 – FluoGuide A/S (“FluoGuide” or the “Company”) hereby publishes...
25 February, 2026
FluoGuide A/S publishes interim report for Q4 2025
Copenhagen, Denmark, 25 February 2026 – Fluoguide A/S (“FluoGuide” or the “Company”) today releases its...
20 February, 2026
FDA clears FluoGuide’s IND for FG001 in High-Grade Glioma; U.S. clinical trial remains on track
Copenhagen, Denmark, 20 February 2026 – FluoGuide A/S (“FluoGuide” or the “Company”), a biotech company...
FluoGuide A/S will publish its Annual Report 2025 on Wednesday, 25 February 2026. Later that day, CEO Morten Albrechtsen and CFO Ole...
Copenhagen, Denmark, 21 January 2026 – FluoGuide A/S (“FluoGuide” or the “Company”), a biotech company...
2025
Copenhagen, Denmark, 19 December 2025 – FluoGuide A/S (“FluoGuide” or the “Company”), a biotech company...
